Evidence map›Paper›PMID 36557074›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Association of Uric Acid Albumin Ratio with Recurrence of Atrial Fibrillation after Cryoballoon Catheter Ablation.

Mehmet Baran Karataş, Gündüz Durmuş, Ahmet Zengin, Murat Gökalp, Mert İlker Hayıroğlu, Tufan Çınar, Kadir Gürkan, Neşe Çam

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Progress of uric acid in cardiovascular disease.Cardiovascular endocrinology & metabolism · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mehmet Baran KarataşDepartment of Cardiology, Health Sciences University, Siyami Ersek Cardiovascular and Thoracic Surgery Center, 34668 Istanbul, Turkey.ORCID 0000-0001-7578-8451
Gündüz DurmuşDepartment of Cardiology, Health Sciences University, Siyami Ersek Cardiovascular and Thoracic Surgery Center, 34668 Istanbul, Turkey.
Ahmet ZenginDepartment of Cardiology, Health Sciences University, Siyami Ersek Cardiovascular and Thoracic Surgery Center, 34668 Istanbul, Turkey.
Murat GökalpDepartment of Cardiology, Health Sciences University, Siyami Ersek Cardiovascular and Thoracic Surgery Center, 34668 Istanbul, Turkey.ORCID 0000-0002-5978-5362
Mert İlker HayıroğluDepartment of Cardiology, Health Sciences University, Siyami Ersek Cardiovascular and Thoracic Surgery Center, 34668 Istanbul, Turkey.
Tufan ÇınarDepartment of Cardiology, Health Sciences University, Sultan Abdulhamid Han Training and Research Hospital, 34668 Istanbul, Turkey.ORCID 0000-0001-8188-5020
Kadir GürkanDepartment of Cardiology, Health Sciences University, Siyami Ersek Cardiovascular and Thoracic Surgery Center, 34668 Istanbul, Turkey.
Neşe ÇamDepartment of Cardiology, Health Sciences University, Siyami Ersek Cardiovascular and Thoracic Surgery Center, 34668 Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Despite improvements in the technology of catheter ablation of atrial fibrillation (AF), recurrences are still a major problem, even after a successful procedure. The uric acid/albumin ratio (UAR), which is an inexpensive and simple laboratory parameter, has recently been introduced in the literature as a predictor of adverse cardiovascular events. Hence, we aimed to investigate the relationship between the UAR and AF recurrence after catheter ablation. Methods: A total of 170 patients who underwent successful catheter ablation for AF were included. The primary outcome was the late recurrence after treatment. The recurrence (+) and recurrence (−) groups were compared for clinical, laboratory and procedural characteristics as well as the predictors of recurrence assessed by regression analysis. Results: In our study population, 53 (26%) patients developed AF recurrence after catheter ablation. Mean UAR was higher in the recurrence (+) group compared to recurrence (−) group (2.4 ± 0.9 vs. 1.8 ± 0.7, p < 0.01). In multivariable regression analysis, left atrial diameter (HR: 1.08, 95% CI: 1.01−1.16, p = 0.01) and UAR (HR:1.36, 95% CI: 1.06−1.75, p = 0.01) were found to be independent predictors of recurrence. In ROC analysis, the UAR > 1.67 predicted recurrence with a sensitivity of 77% and a specificity of 57% (AUC 0.68, p < 0.01). Conclusion: For the first time in the literature, the UAR were found to be correlated independently with AF recurrence after catheter ablation.

Indexed as

Atrial FibrillationCatheter AblationHumansRecurrenceRisk FactorsTreatment OutcomeUric AcidUric Acidatrial fibrillationcatheter ablationrecurrenceuric acid/albumin ratio

Identifiers

PMID36557074
PMCPMC9784806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.